You can view the research column published every month by SMC Laboratories.
2025.01.29
Introduction of DDC-Induced Cholestatic Liver Disease Mouse Model
We would like to introduce mice model of primary sclerosing cholangitis (PSC), as well as 3,5-Diethoxycarbonyl…
READ MORE
2025.01.29
Pre-clinical studies for Cholestatic Liver Diseases: Bile Duct Ligation model
We would like to share with you about our Bile duct ligation (BDL) model, known as a disease model mice for ch…
READ MORE
2025.01.29
Positive control for CCl4 mouse model
We would like to introduce our carbon tetrachloride (CCl4)-induced liver fibrosis model, which is a widely use…
READ MORE
2025.01.29
Proteinuria in the Adriamycin model
When discussing our mouse models of chronic kidney disease (CKD), we are often asked about proteinuria as a ur…
READ MORE
2025.01.29
Drug efficacy evaluation study for fibrotic diseases involving multiple organs
We want to introduce a paper by Insilico Medicine, a company that focuses on fibrosis to develop drugs, and af…
READ MORE
2025.01.29
Introduction of the paper using our UUO model
Today, we would like to introduce a paper published by our client using our Chronic Kidney Disease model. &nbs…
READ MORE
2025.01.29
Positive control for UUO kidney fibrosis
We would like to introduce about a newly established positive control – an ALK5 inhibitor – for ou…
READ MORE
2025.01.29
Adenine-induced nephropathy model
We would like to introduce our Adenine-induced nephropathy mouse model, a chronic kidney disease (CKD) model. …
READ MORE
2025.01.29
Biomarker for kidney damage in Adriamycin model
We would like to introduce a non-invasive biomarkers for kidney disease models. Urine NGAL level…
READ MORE
2025.01.29
Adriamycin-induced nephropathy model
We would like to introduce a chronic kidney disease (CKD) and our Adriamycin-induced nephropathy (ADR) mouse m…
READ MORE
